Primary |
Colorectal Cancer Metastatic |
42.0% |
Prostate Cancer Metastatic |
10.3% |
Colorectal Cancer |
9.8% |
Prophylaxis |
7.4% |
Non-small Cell Lung Cancer Metastatic |
5.4% |
Non-small Cell Lung Cancer |
4.4% |
Hypertension |
3.2% |
Adenocarcinoma |
2.5% |
Age-related Macular Degeneration |
2.5% |
Cholangiocarcinoma |
2.2% |
Hormone Replacement Therapy |
2.0% |
Hormone Therapy |
1.2% |
Product Used For Unknown Indication |
1.2% |
Anxiety |
1.0% |
Diabetes Mellitus |
1.0% |
Diabetic Retinal Oedema |
1.0% |
Colon Cancer Metastatic |
0.7% |
Constipation |
0.7% |
Pain |
0.7% |
Routine Health Maintenance |
0.7% |
|
Proteinuria |
20.3% |
Death |
10.1% |
Hyperkalaemia |
5.8% |
Pleural Effusion |
5.8% |
Posterior Reversible Encephalopathy Syndrome |
5.8% |
Urinary Tract Infection |
5.8% |
Vomiting |
5.8% |
Endophthalmitis |
4.3% |
Impaired Healing |
4.3% |
Anal Fistula |
2.9% |
Confusional State |
2.9% |
Dermatitis Bullous |
2.9% |
Disease Progression |
2.9% |
Enterovesical Fistula |
2.9% |
Folliculitis |
2.9% |
General Physical Health Deterioration |
2.9% |
Hip Fracture |
2.9% |
Hypotension |
2.9% |
Intestinal Perforation |
2.9% |
Large Intestine Perforation |
2.9% |
|
Secondary |
Colorectal Cancer Metastatic |
50.1% |
Prostate Cancer Metastatic |
10.2% |
Colorectal Cancer |
7.2% |
Product Used For Unknown Indication |
4.7% |
Non-small Cell Lung Cancer Metastatic |
4.6% |
Non-small Cell Lung Cancer |
4.5% |
Hormone Replacement Therapy |
2.8% |
Hypertension |
2.7% |
Age-related Macular Degeneration |
2.2% |
Pseudomyxoma Peritonei |
1.7% |
Prophylaxis |
1.6% |
Hormone Therapy |
1.4% |
Adenocarcinoma |
1.0% |
Cholangiocarcinoma |
1.0% |
Convulsion |
0.9% |
Colon Cancer Metastatic |
0.7% |
Macular Degeneration |
0.7% |
Anxiety |
0.7% |
Nausea |
0.7% |
Pain |
0.7% |
|
Vomiting |
11.9% |
Proteinuria |
9.7% |
Hyperkalaemia |
8.1% |
Diarrhoea |
6.4% |
Pneumothorax |
5.9% |
Death |
5.1% |
Neutropenia |
5.1% |
Pyrexia |
5.1% |
Pneumonia Necrotising |
4.7% |
Intestinal Perforation |
4.2% |
Sudden Death |
4.2% |
Hypertension |
3.8% |
Pleural Effusion |
3.8% |
Sepsis |
3.8% |
Febrile Neutropenia |
3.4% |
Cholecystitis Acute |
3.0% |
Malaise |
3.0% |
Pulmonary Embolism |
3.0% |
Respiratory Failure |
3.0% |
Syncope |
3.0% |
|
Concomitant |
Colorectal Cancer Metastatic |
26.9% |
Colon Cancer |
25.2% |
Rectal Cancer |
25.2% |
Non-small Cell Lung Cancer |
7.6% |
Age-related Macular Degeneration |
2.5% |
Atrial Fibrillation |
0.8% |
Cardiovascular Event Prophylaxis |
0.8% |
Colorectal Cancer |
0.8% |
Constipation |
0.8% |
Diabetes Mellitus |
0.8% |
Diabetic Macular Edema |
0.8% |
Diabetic Retinal Oedema |
0.8% |
Heart Attack |
0.8% |
Heart Disease, Unspecified |
0.8% |
Hypokalaemia |
0.8% |
Oedema Due To Cardiac Disease |
0.8% |
Off Label Use |
0.8% |
Pelvic Pain |
0.8% |
Product Used For Unknown Indication |
0.8% |
Tachycardia |
0.8% |
|
Posterior Reversible Encephalopathy Syndrome |
21.4% |
Xerosis |
21.4% |
Poor Quality Drug Administered |
7.1% |
Pulmonary Fibrosis |
7.1% |
Renal Failure Acute |
7.1% |
Retinal Detachment |
7.1% |
Seasonal Allergy |
7.1% |
Stomatitis |
7.1% |
Subretinal Fluid |
7.1% |
Visual Acuity Reduced |
7.1% |
|